首页> 外文期刊>Nature >New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
【24h】

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

机译:新的线粒体DNA合成使NLRP3炎性体活化

获取原文
获取原文并翻译 | 示例
       

摘要

Dysregulated NLRP3 inflammasome activity results in uncontrolled inflammation, which underlies many chronic diseases. Although mitochondrial damage is needed for the assembly and activation of the NLRP3 inflammasome, it is unclear how macrophages are able to respond to structurally diverse inflammasome-activating stimuli. Here we show that the synthesis of mitochondrial DNA (mtDNA), induced after the engagement of Toll-like receptors, is crucial for NLRP3 signalling. Toll-like receptors signal via the MyD88 and TRIF adaptors to trigger IRF1-dependent transcription of CMPK2, a rate-limiting enzyme that supplies deoxyribonucleotides for mtDNA synthesis. CMPK2-dependent mtDNA synthesis is necessary for the production of oxidized mtDNA fragments after exposure to NLRP3 activators. Cytosolic oxidized mtDNA associates with the NLRP3 inflammasome complex and is required for its activation. The dependence on CMPK2 catalytic activity provides opportunities for more effective control of NLRP3 inflammasome-associated diseases.
机译:NLRP3炎症小体活性失调导致炎症失控,这是许多慢性疾病的基础。尽管NLRP3炎性小体的组装和激活需要线粒体损伤,但尚不清楚巨噬细胞如何对结构多样的炎性小体激活刺激做出反应。在这里,我们表明,Toll样受体参与后诱导的线粒体DNA(mtDNA)的合成对于NLRP3信号传导至关重要。 Toll样受体通过MyD88和TRIF衔接子发出信号,以触发IRF1依赖性的CMPK2转录,CMPK2是一种限速酶,为mtDNA合成提供脱氧核糖核苷酸。暴露于NLRP3激活剂后,依赖CMPK2的mtDNA合成对于氧化的mtDNA片段的生产是必需的。胞质氧化的mtDNA与NLRP3炎症小体复合物缔合,并且是激活它所必需的。对CMPK2催化活性的依赖性为更有效地控制NLRP3炎性体相关疾病提供了机会。

著录项

  • 来源
    《Nature》 |2018年第7717期|198-203|共6页
  • 作者单位

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

    Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA;

    Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol, Los Angeles, CA 90048 USA;

    Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA;

    Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA;

    Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA;

    Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA;

    Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:35

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号